FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 30 filers reported holding FUSION PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,598,379 | $12,659,000 | 4.47% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $23,347,000 | 3.00% |
| JOHNSON & JOHNSON | 3,670,516 | $29,070,000 | 2.55% |
| Sio Capital Management, LLC | 259,763 | $2,057,000 | 0.66% |
| Orbimed Advisors | 3,224,770 | $25,540,000 | 0.28% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $20,210,000 | 0.20% |
| Rock Springs Capital Management LP | 948,327 | $7,511,000 | 0.16% |
| Perceptive Advisors | 1,254,607 | $9,936,000 | 0.14% |
| AlphaCentric Advisors LLC | 71,500 | $566,000 | 0.14% |
| Artal Group S.A. | 750,000 | $5,940,000 | 0.13% |